ATE100453T1 - Sulfhydryl enthaltende tricylische lactame und ihre pharmakologische verwendung. - Google Patents

Sulfhydryl enthaltende tricylische lactame und ihre pharmakologische verwendung.

Info

Publication number
ATE100453T1
ATE100453T1 AT88121850T AT88121850T ATE100453T1 AT E100453 T1 ATE100453 T1 AT E100453T1 AT 88121850 T AT88121850 T AT 88121850T AT 88121850 T AT88121850 T AT 88121850T AT E100453 T1 ATE100453 T1 AT E100453T1
Authority
AT
Austria
Prior art keywords
tricylic
lactame
pharmacological use
sulfhydryl containing
hydrogen
Prior art date
Application number
AT88121850T
Other languages
English (en)
Inventor
Gary A Flynn
Douglas W Beight
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE100453T1 publication Critical patent/ATE100453T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88121850T 1987-12-30 1988-12-29 Sulfhydryl enthaltende tricylische lactame und ihre pharmakologische verwendung. ATE100453T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/139,485 US4824832A (en) 1987-12-30 1987-12-30 Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
EP88121850A EP0322914B1 (de) 1987-12-30 1988-12-29 Sulfhydryl enthaltende tricylische Lactame und ihre pharmakologische Verwendung

Publications (1)

Publication Number Publication Date
ATE100453T1 true ATE100453T1 (de) 1994-02-15

Family

ID=22486887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88121850T ATE100453T1 (de) 1987-12-30 1988-12-29 Sulfhydryl enthaltende tricylische lactame und ihre pharmakologische verwendung.

Country Status (18)

Country Link
US (1) US4824832A (de)
EP (1) EP0322914B1 (de)
JP (1) JP2681291B2 (de)
KR (1) KR0128158B1 (de)
CN (1) CN1034721A (de)
AT (1) ATE100453T1 (de)
AU (1) AU611984B2 (de)
CA (1) CA1336191C (de)
DE (1) DE3887307T2 (de)
DK (1) DK725988A (de)
ES (1) ES2061621T3 (de)
FI (1) FI886005A7 (de)
HU (2) HU204050B (de)
IL (1) IL88810A (de)
NO (1) NO885812L (de)
NZ (1) NZ227432A (de)
PT (1) PT89346B (de)
ZA (1) ZA889542B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
DK0492369T3 (da) * 1990-12-21 1997-10-13 Merrell Pharma Inc Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
US5308841A (en) * 1990-12-21 1994-05-03 Merrell Dow Pharmaceuticals Inc. Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
ATE155143T1 (de) * 1991-09-27 1997-07-15 Merrell Pharma Inc 2-substituierte indan-2-mercaptoacetylamid- verbindungen mit enkephalinase und ace- hemmwirkung
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
DE69317764T2 (de) * 1992-02-14 1998-07-30 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
ATE182892T1 (de) * 1992-05-15 1999-08-15 Merrell Pharma Inc Mercaptoacetylamide von pyridazo(1,2-a>(1,2>- diazepin -derivaten als eukephalinase und ace- inhibitoren
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
US5420271A (en) * 1992-08-24 1995-05-30 Merrell Dow Pharmaceuticals, Inc. 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
PT669936E (pt) * 1992-10-30 2001-04-30 Merrell Pharma Inc Derivados de lactama biciclica de mercaptoacetilamida uteis como inibidores de encefalinase e de ace
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
NZ275939A (en) * 1993-11-19 1997-04-24 Merrell Pharma Inc Preparation of (s)-1-[2(s)-(1,3-dihydro-1,3-dioxoisoindol-2-yl)-1-oxo-3-phenylpropyl ]-1,2,3,4-tetrahydropyridine-2-carboxylic acid methyl ester
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
JP3561753B2 (ja) * 1994-02-14 2004-09-02 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ及びaceの阻害剤として有用な、新規な2−置換インダン−2−メルカプトアセチルアミドジスルフィド誘導体類
PT750631E (pt) * 1994-02-14 2000-07-31 Merrell Pharma Inc Novos derivados de dissulfureto de mercapto-aacetilamido-1,3,4,5-tetra-hidro-benzo¬c)azepin-3-ona uteis como inibidores de encefalinase e ace
JP3596778B2 (ja) * 1994-02-14 2004-12-02 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ及びaceの阻害剤として有用な、新規なメルカプトアセチルアミドジスルフィド誘導体類
CA2183313C (en) * 1994-02-14 2001-01-02 Gary A. Flynn Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
ATE246927T1 (de) * 1994-03-24 2003-08-15 Merrell Pharma Inc Cholesterin senkende mercaptoacetylamiddisulfidderivate
PT751783E (pt) * 1994-03-24 2000-05-31 Merrell Pharma Inc Derivados aminoacetilmercapto hipocolesterolemicos antiateroscleroticos e hipotrigliceridemicos
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
CN1241924C (zh) * 1994-12-21 2006-02-15 阿温蒂斯药物公司 制备脑啡肽酶与血管紧张素转化酶抑制剂中间体的新方法及其中间体
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use
US20030229007A1 (en) * 2002-05-30 2003-12-11 Roberto Levi Form of human renin and its use as a target in treatments for cardiac ischemia and arrhythmia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185680A (en) * 1962-10-16 1965-05-25 American Home Prod Reduced benzodiazepinium compounds
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
CA1337654C (en) * 1986-06-13 1995-11-28 Gary A. Flynn Fused tricyclic lactams as antihypertensive agents

Also Published As

Publication number Publication date
JP2681291B2 (ja) 1997-11-26
NO885812D0 (no) 1988-12-29
HU895880D0 (en) 1990-02-28
US4824832A (en) 1989-04-25
JPH01203382A (ja) 1989-08-16
AU2736888A (en) 1989-07-06
DE3887307D1 (de) 1994-03-03
KR890009927A (ko) 1989-08-04
DK725988D0 (da) 1988-12-28
NZ227432A (en) 1990-11-27
IL88810A (en) 1993-08-18
IL88810A0 (en) 1989-07-31
KR0128158B1 (ko) 1998-04-04
PT89346B (pt) 1993-08-31
ES2061621T3 (es) 1994-12-16
CA1336191C (en) 1995-07-04
HUT49137A (en) 1989-08-28
AU611984B2 (en) 1991-06-27
HU200181B (en) 1990-04-28
EP0322914A2 (de) 1989-07-05
DK725988A (da) 1989-07-01
PT89346A (pt) 1989-12-29
EP0322914A3 (en) 1990-12-27
FI886005A7 (fi) 1989-07-01
ZA889542B (en) 1989-09-27
CN1034721A (zh) 1989-08-16
HU204050B (en) 1991-11-28
EP0322914B1 (de) 1994-01-19
DE3887307T2 (de) 1994-05-05
NO885812L (no) 1989-07-03

Similar Documents

Publication Publication Date Title
DE3887307D1 (de) Sulfhydryl enthaltende tricylische Lactame und ihre pharmakologische Verwendung.
EP0262399A3 (en) Cyclic enol derivatives, production and use thereof
NZ212750A (en) 3-acylamino-2-azetidinone derivatives useful as intermediates in the preparation of antibacterial agents
IL99525A0 (en) Fused ring analogs of nitrogen containing nonaromatic heterocycles
IE882929L (en) "immunomodulatory azaspiranes"
EP1035123A4 (de) Neue heterozyklische verbindungen
ES2175615T3 (es) Derivados de azaindol etilamina como agentes de union al receptor nicotinico de acetilcolina.
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
ZA93218B (en) Heterocyclic compounds and their preparation and use.
ES2031892T3 (es) Agentes antialergicos y antiinflamatorios.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE91128T1 (de) 5,11-dihydro-6h-dipyrido (3,2-b:2',3'-e>diazepin- 6-one und deren verwendung in der vorbeugung und behandlung von aids.
IL95012A0 (en) Hemoregulatory peptides
ATE121395T1 (de) Cumarinderivate, ihre herstellung und ihre verwendung zur behandlung von zerebrovaskulären störungen.
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE71092T1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
GR852040B (de)
DE3866719D1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
LT2199B (lt) 2-triazolidinono dariniu gavimo budas
EP0574271A3 (de)
DE3666430D1 (en) Condensed seven-membered heterocyclic compounds, their production and use
DE69214205D1 (de) Neue Isatineoxime Derivate, ihre Herstellung und Verwendung
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties